B3GAT1 and prostate cancer: This eQTL is predicted to be specific to NK cells, and colocalises with a GWAS63 risk locus for prostate cancer (PP4 = 0.949), with decreased NK cell B3GAT1 expression being associated with increased prostate cancer risk.